Central, K3CIK 21037251 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
6 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Revolution Medicines Inc | 900.4K | $71.72M | 67.2% | +900.4K | New Position |
| 2 | Protagonist Therapeutics Inc | 189.8K | $16.58M | 15.5% | +189.8K | New Position |
| 3 | Arrivent Biopharma Inc | 644.8K | $12.97M | 12.2% | +644.8K | New Position |
| 4 |
| Cogent Biosciences Inc |
| 100.0K |
| $3.55M |
| 3.3% |
| +100.0K |
| New Position |
| 5 | I Mab | 414.0K | $1.65M | 1.5% | +414.0K | New Position |
| 6 | Korro Bio Inc | 30.3K | $242.4K | 0.2% | +30.3K | New Position |